Comparison between Modern Diagnostic IPO and Swastika Castal IPO.
Modern Diagnostic IPO is a SME Fixed Price IPO proposed to list at BSE SME while Swastika Castal IPO is a SME Fixed Price proposed to list at BSE SME.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Accurate Securities & Registry Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Horizon Financial Consultants Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Modern Diagnostic IPO is up to ₹35.04 Cr whereas the issue size of the Swastika Castal IPO is up to ₹13.35 Cr. The final issue price of Modern Diagnostic IPO is ₹90.00 per share and of Swastika Castal IPO is ₹65.00 per share.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹85.00 per share | |
| Issue Price (Upper) | ₹90.00 per share | |
| Issue Price (Final) | ₹90.00 per share | ₹65.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 2000 shares |
| Fresh Issue Size | 38,92,800 shares | 20,54,000 shares |
| Fresh Issue Size (Amount) | up to ₹35.04 Cr | up to ₹13.35 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,92,800 shares | 20,54,000 shares |
| Issue Size Total (Amount) | up to ₹35.04 Cr | up to ₹13.35 Cr |
Modern Diagnostic IPO opens on Dec 31, 2025, while Swastika Castal IPO opens on Jul 21, 2025. The closing date of Modern Diagnostic IPO and Swastika Castal IPO is Jan 02, 2026, and Jul 23, 2025, respectively.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Anchor Bid Date | Dec 30, 2025 | |
| Issue Open | Dec 31, 2025 | Jul 21, 2025 |
| Issue Close | Jan 02, 2026 | Jul 23, 2025 |
| Basis Of Allotment (Tentative) | Jan 05, 2026 | Jul 24, 2025 |
| Initiation of Refunds (Tentative) | Jan 06, 2026 | Jul 25, 2025 |
| Credit of Share (Tentative) | Jan 06, 2026 | Jul 25, 2025 |
| Listing date (Tentative) | Jan 07, 2026 | Jul 28, 2025 |
| Anchor Lockin End date 1 | Feb 03, 2026 | |
| Anchor Lockin End date 2 | Apr 04, 2026 |
Modern Diagnostic IPO P/E ratio is 11.04, as compared to Swastika Castal IPO P/E ratio of 14.8.
| Modern Diagnostic IPO | Swastika Castal IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Modern Diagnostic & Research Centre Ltd.'s revenue increased by 15% and profit after tax (PAT) rose by 55% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Swastika Castal Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 305% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.85 | 73.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.04 | 14.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹135.89 Cr. | ₹53.07 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.21 | 28.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.18 | 32.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.07 | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.15 | ₹4.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 43.27 | 24.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Modern Diagnostic IPO Retail Individual Investors (RII) are offered 13,63,200 shares while in Swastika Castal IPO retail investors are offered 13,63,200 shares. Qualified Institutional Buyers (QIB) are offered 7,82,400 shares in Modern Diagnostic IPO and 0 shares in Swastika Castal IPO.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| Anchor Investor Reservation | 11,61,600 shares | |
| Market Maker Reservation | 2,06,400 shares | 1,10,000 shares |
| QIB | 7,82,400 shares | 0 shares |
| NII | 5,85,600 shares | 10,26,000 shares |
| RII | 13,63,200 shares | 10,28,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 38,92,800 shares | 20,54,000 shares |
Modern Diagnostic IPO subscribed 376.90x in total, whereas Swastika Castal IPO subscribed 5.08x.
| Modern Diagnostic IPO | Swastika Castal IPO | |
|---|---|---|
| QIB (times) | 193.51x | |
| NII (times) | 702.08x | 2.42x |
| Big NII (times) | 855.83x | |
| Small NII (times) | 386.91x | |
| RII (times) | 342.46x | 7.75x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 376.90x | 5.08x |
